530 related articles for article (PubMed ID: 3012622)
1. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
2. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
Imai S
Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
[TBL] [Abstract][Full Text] [Related]
3. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
4. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
6. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
Strang G; Rickinson AB
Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
[TBL] [Abstract][Full Text] [Related]
7. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
[TBL] [Abstract][Full Text] [Related]
8. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
Tosato G; Straus S; Henle W; Pike SE; Blaese RM
J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
[TBL] [Abstract][Full Text] [Related]
9. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
Wang F; Blaese RM; Zoon KC; Tosato G
J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
Royston I; Sullivan JL; Periman PO; Perlin E
N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
[TBL] [Abstract][Full Text] [Related]
12. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
Strang G; Rickinson AB
Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
Wingate PJ; McAulay KA; Anthony IC; Crawford DH
J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
Andersson J
Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
[TBL] [Abstract][Full Text] [Related]
15. [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection].
Konno M
Hokkaido Igaku Zasshi; 1989 Mar; 64(2):125-38. PubMed ID: 2543617
[TBL] [Abstract][Full Text] [Related]
16. B lymphocytopenia in infectious mononucleosis.
Sumaya CV; Keightley RG
Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
[TBL] [Abstract][Full Text] [Related]
17. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
Kwon KW
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
19. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
Jondal M
Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]